Recurrent ventilator-associated pneumonia in severe Covid-19 ARDS patients requiring ECMO support

Autor: Elena Collado-Lledó, Quentin Moyon, Juliette Chommeloux, Marc Pineton de Chambrun, Guillaume Hékimian, Ouriel Saura, David Lévy, Matthieu Schmidt, Alain Combes, Charles-Edouard Luyt, Lucie Le Fevre
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: Annals of Intensive Care, Vol 14, Iss 1, Pp 1-11 (2024)
Druh dokumentu: article
ISSN: 2110-5820
DOI: 10.1186/s13613-024-01295-1
Popis: Abstract Objective To describe ventilator-associated pneumonia (VAP) recurrence in COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO) support, and to evaluate the impact of antimicrobial treatment duration of the first VAP episode on VAP recurrence. Methods Adult patients with COVID-19 severe pneumonia on ECMO admitted between March 2020 and January 2022 were retrospectively included. Primary outcome was incidence of VAP recurrence, and secondary outcome was the impact of duration of antimicrobial treatment on VAP recurrence. Results Among the 252 included patients, 226 (90%) developed a first VAP. Sixteen had lung abscess and were excluded, leaving 210 patients. VAP recurrence occurred in 172 patients (82%), with a median (IQR) time from first VAP to recurrence of 10 (7–13) days. Pseudomonas aeruginosa and Enterobacteriaceae were respectively responsible for 28% and 52% of first VAP, and 51% and 62% of first recurrence episodes. Among the 210 patients with a first VAP, 158 (75%) received a short course of antibiotics [
Databáze: Directory of Open Access Journals
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje